跳至主要内容
临床试验/IRCT2015050322065N1
IRCT2015050322065N1已完成3 期

prevention of contrast induced nephropathy(CIN) in pateints with some degree of chronic kidney disease (CKD) undergoing coronary angioplasty/graphy with sodium potassium citrate solution(shohl's solution)

Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences0 个研究点目标入组 190 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
190

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • all adult patients (more than 18 years old) candidate for elective coronary angioplasty/graphy and have CKD (at least stage 2)
  • Exclusion criteria: ESRD (GFR less than 15cc per min); AKI; exposure to contrast within last 10 days; history of sensitivity to contrast media; pulmonary edema; multiple myeloma; history of (diarrhea, vomiting, dehydration status, bleeding);
  • pregnancy; drug history of (NAC, teofiline, dopamine, fenoldopam, manitol and
  • NaHCO3) 48 hours before intervention; consumption of nephrotoxic drugs 48 hours before till one week following the intervention; electrolytes disturbance (i.e hyperkalemia or alkalosis) or GFR more than 90 cc per min; refusal to participate

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences

相似试验